• Health & Medicine

Study opens door to targeted treatments for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments. Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.

5 September 2016

• Health & Medicine
• Science & Technology

News digest – obesity in primary schools, the Crick, artificial intelligence and… Tasmanian devils?

Worrying new statistics highlight a childhood obesity epidemic, and could Tasmanian devils survive extinction from a deadly cancer? Worrying new statistics highlight a childhood obesity epidemic, and could Tasmanian devils survive extinction from a deadly cancer?

3 September 2016

• Health & Medicine

New data on cancer treatment to help improve care

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England. Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

31 August 2016

• Science & Technology
• Health & Medicine

News digest – apricot kernels, CRISPR, waiting time target missed (again) and… is tap water bad?

Apricot kernels, CRISPR, waiting time target missed and is tap water bad? Here's this week's cancer news. Apricot kernels, CRISPR, waiting time target missed and is tap water bad? Here's this week's cancer news.

13 August 2016

• For Researchers

Recognising excellence: CRUK prizewinners

Our awards support and celebrate the incredible work, dedication and scientific innovation of those at the forefront of advancing our ability to defeat cancer. Our awards support and celebrate the incredible work, dedication and scientific innovation of those at the forefront of advancing our ability to defeat cancer.

10 August 2016

CRT and Alta Innovations join forces to commercialise world-leading research

CRT, the University of Birmingham and Alta Innovations, have signed an agreement to work together to develop and commercialise the university’s cancer research. CRT, the University of Birmingham and Alta Innovations, have signed an agreement to work together to develop and commercialise the university’s cancer research.

9 August 2016

• Science & Technology
• Health & Medicine

News digest – Anti-malaria drug, a chemotherapy class, e-cigarettes and……a fossil?

Here's this week's news roundup. Here's this week's news roundup.

29 July 2016

• Policy & Insight

Expert opinion: Professor Karen Vousden, our new chief scientist

Professor Karen Vousden is our new chief scientist. We caught up with her to get a sneak peak at what this involves, and what she sees as the hot topics for future research. Professor Karen Vousden is our new chief scientist. We caught up with her to get a sneak peak at what this involves, and what she sees as the hot topics for future research.

27 July 2016

• Health & Medicine

Tackling hard-to-treat cancers – what, how and why?

Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours. Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.

20 July 2016

• Science & Technology
• Health & Medicine

Making a special case – how to boost brain tumour research

Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them. Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them.

19 July 2016

• Science & Technology
• Health & Medicine

News digest - hidden ‘ginger gene’, missed targets, undiagnosed lung cancers and... Kim Jong-Un’s secret formula?

Here's this week's cancer news. Here's this week's cancer news.

16 July 2016

• For Researchers

Asking the right questions in clinical research

We have made changes to our clinical research funding structures, and introduced a new Statement of Intent to provide clarity around the types of research. We have made changes to our clinical research funding structures, and introduced a new Statement of Intent to provide clarity around the types of research.

11 July 2016